Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 223

1.

Safety and effectiveness of hormonal contraception for women who use opioids: a systematic review.

Ti A, Stone RH, Whiteman M, Curtis KM.

Contraception. 2019 Sep 1. pii: S0010-7824(19)30403-2. doi: 10.1016/j.contraception.2019.08.006. [Epub ahead of print]

PMID:
31484059
2.

Changes in US health care provider attitudes related to contraceptive safety before and after the release of National Guidance.

Zapata LB, Morgan IA, Curtis KM, Folger SG, Whiteman MK.

Contraception. 2019 Jul 29. pii: S0010-7824(19)30370-1. doi: 10.1016/j.contraception.2019.07.142. [Epub ahead of print]

PMID:
31369735
3.

Healthcare provider knowledge regarding oral contraception effectiveness for women with a history of bariatric malabsorptive procedures.

Shah JP, Jatlaoui TC, Zapata LB, Curtis KM, Pagano HP, Whiteman MK.

Surg Obes Relat Dis. 2019 Aug;15(8):1355-1361. doi: 10.1016/j.soard.2019.06.007. Epub 2019 Jun 17.

4.

Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.

Ti A, Curtis KM.

Eur J Contracept Reprod Health Care. 2019 Apr;24(2):109-116. doi: 10.1080/13625187.2019.1569610. Epub 2019 Mar 28.

PMID:
30920314
5.

Factors associated with postpartum use of long-acting reversible contraception.

Oduyebo T, Zapata LB, Boutot ME, Tepper NK, Curtis KM, D'Angelo DV, Marchbanks PA, Whiteman MK.

Am J Obstet Gynecol. 2019 Jul;221(1):43.e1-43.e11. doi: 10.1016/j.ajog.2019.03.005. Epub 2019 Mar 15.

PMID:
30885772
6.

In Reply.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Curtis KM.

Obstet Gynecol. 2019 Mar;133(3):582-583. doi: 10.1097/AOG.0000000000003145. No abstract available.

PMID:
30801457
7.

Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.

Ermias Y, Morgan IA, Curtis KM, Whiteman MK, Horton LG, Zapata LB.

Contraception. 2019 May;99(5):300-305. doi: 10.1016/j.contraception.2019.01.005. Epub 2019 Feb 11.

PMID:
30763582
8.

Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.

Tepper NK, Jeng G, Curtis KM, Boutot ME, Boulet SL, Whiteman MK.

Obstet Gynecol. 2019 Mar;133(3):533-540. doi: 10.1097/AOG.0000000000003135.

PMID:
30741807
9.

Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.

Morgan IA, Zapata LB, Curtis KM, Whiteman MK.

J Pediatr Adolesc Gynecol. 2019 Aug;32(4):402-408. doi: 10.1016/j.jpag.2019.01.007. Epub 2019 Feb 4.

PMID:
30731216
10.

Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.

Morgan IA, Ermias Y, Zapata LB, Curtis KM, Whiteman MK.

J Adolesc Health. 2019 Feb;64(2):211-218. doi: 10.1016/j.jadohealth.2018.08.012. Epub 2018 Nov 2.

PMID:
30392865
11.

Contraceptive Counseling in Clinical Settings: An Updated Systematic Review.

Zapata LB, Pazol K, Dehlendorf C, Curtis KM, Malcolm NM, Rosmarin RB, Frederiksen BN.

Am J Prev Med. 2018 Nov;55(5):677-690. doi: 10.1016/j.amepre.2018.07.006. Review.

PMID:
30342631
12.

Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, Marchbanks PA, Curtis KM.

Obstet Gynecol. 2018 Oct;132(4):895-905. doi: 10.1097/AOG.0000000000002822.

PMID:
30204688
13.

Dissemination and use of WHO family planning guidance and tools: a qualitative assessment.

Kraft JM, Oduyebo T, Jatlaoui TC, Curtis KM, Whiteman MK, Zapata LB, Gaffield ME.

Health Res Policy Syst. 2018 May 22;16(1):42. doi: 10.1186/s12961-018-0321-1.

14.

Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits.

Tepper NK, Godfrey EM, Folger SG, Whiteman MK, Marchbanks PA, Curtis KM.

J Womens Health (Larchmt). 2018 Apr;27(4):413-417. doi: 10.1089/jwh.2018.6985. Epub 2018 Mar 19.

PMID:
29634450
15.

Health Care Provider Perceptions of the Safety of IUDs for Women with HIV.

Simmons KB, Zapata L, Curtis KM.

Perspect Sex Reprod Health. 2018 Jun;50(2):67-73. doi: 10.1363/psrh.12056. Epub 2018 Mar 30.

PMID:
29603597
16.

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.

Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME.

Int J Gynaecol Obstet. 2018 Jun;141(3):287-294. doi: 10.1002/ijgo.12455. Epub 2018 Feb 22. Review.

17.

Reply.

Tepper NK, Curtis KM, Champaloux SW.

Am J Obstet Gynecol. 2018 Mar;218(3):364-365. doi: 10.1016/j.ajog.2017.11.586. Epub 2017 Nov 23. No abstract available.

PMID:
29175249
18.

Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.

Simmons KB, Haddad LB, Nanda K, Curtis KM.

BJOG. 2018 Jun;125(7):804-811. doi: 10.1111/1471-0528.15027. Epub 2017 Dec 15.

19.

Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response - United States, September 2016.

Kroelinger CD, Romero L, Lathrop E, Cox S, Morgan I, Frey MT, Warner L, Curtis KM, Pazol K, Barfield WD, Meaney-Delman D, Jamieson DJ.

MMWR Morb Mortal Wkly Rep. 2017 Nov 10;66(44):1230-1235. doi: 10.15585/mmwr.mm6644a6.

20.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK.

MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.

Supplemental Content

Loading ...
Support Center